Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-15-045390

Options or other derivatives

  • Exec. VP & Chief Discovery Off acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Abrams Michael J. Exec. VP & Chief Discovery Off 2015-07-09 Grant or award · Employee Stock Option (right to buy) +35,000 35,000 D: show line 1 in the form
Loading xslF345X03/doc1.xml…